相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of the Use of Low-Dose 4-Factor Prothrombin Complex Concentrate in the Reversal of Direct Oral Anticoagulants in Bleeding Patients
Teresa A. Allison et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2020)
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
Sam Schulman et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals
M. Santibanez et al.
JOURNAL OF CRITICAL CARE (2018)
Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
Jing Tao et al.
JOURNAL OF INTENSIVE CARE (2018)
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Bettina Schenk et al.
THROMBOSIS JOURNAL (2018)
Prothrombin Time Tests for the Monitoring of Direct Oral Anticoagulants and Their Evaluation as Indicators of the Reversal Effect
Kunihiko Nagakari et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2017)
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
Gordon F. Tomaselli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Outcome of intracerebral hemorrhage associated with different oral anticoagulants
Duncan Wilson et al.
NEUROLOGY (2017)
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study
Ammar Majeed et al.
BLOOD (2017)
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro
Nina H. Schultz et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2017)
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
Nina Haagenrud Schultz et al.
THROMBOSIS JOURNAL (2017)
In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate
Stefano Barco et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage
Jamil R. Dibu et al.
NEUROCRITICAL CARE (2016)
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
Jennifer A. Frontera et al.
NEUROCRITICAL CARE (2016)
Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation
Jonathan H. Sin et al.
JOURNAL OF CRITICAL CARE (2016)
Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial
M. Irem Baharoglu et al.
LANCET (2016)
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial
Thorsten Steiner et al.
LANCET NEUROLOGY (2016)
Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhage
E. Herzog et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial
Joshua N. Goldstein et al.
LANCET (2015)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
J. Claude Hemphill et al.
STROKE (2015)
Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors
Ramesh Grandhi et al.
WORLD NEUROSURGERY (2015)
Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate
Hamim Zahir et al.
CIRCULATION (2015)
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers
M. Levi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized, Plasma-Controlled, Phase IIIb Study
Ravi Sarode et al.
CIRCULATION (2013)
Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal
Dar Dowlatshahi et al.
STROKE (2012)
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
Raphael Marlu et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects
Elise S. Eerenberg et al.
CIRCULATION (2011)
分享论文
